Skip to main content

What the FDA labels say about taking them together

Eslicarbazepine and phenytoin

Eslicarbazepine's FDA label of November 10, 2023 names phenytoin in its drug interactions section; the phenytoin labels PlainMeds reads (2) do not name eslicarbazepine. The eslicarbazepine label: “Higher dosage of APTIOM may be necessary and dose adjustment may be needed for phenytoin. Phenobarbital or Primidone:”

Check it at the source: the eslicarbazepine FDA label on DailyMed (effective November 10, 2023, Sumitomo Pharma America, Inc.); the phenytoin FDA label on DailyMed (effective October 15, 2024, Mylan Pharmaceuticals Inc.).

What does the eslicarbazepine label say about phenytoin?

Eslicarbazepine label, drug interactions

Higher dosage of APTIOM may be necessary and dose adjustment may be needed for phenytoin. ( 2.3 , 7.1 , 7.2 ) Phenobarbital or Primidone:

Source: FDA drug label (Aptiom), Sumitomo Pharma America, Inc., effective November 10, 2023 (SPL set 3d0c9554-eaeb-4694-8089-00133fcadce3), via openFDA; the full label on DailyMed

What does the phenytoin label say about eslicarbazepine?

Phenytoin's label (effective October 15, 2024) and its 1 other brand-application label do not name eslicarbazepine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Phenytek), Mylan Pharmaceuticals Inc., effective October 15, 2024 (SPL set 0f94c791-8b07-4b41-927e-c9f28bec5f60), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

9Eslicarbazepine generic labelers
29Phenytoin generic labelers
EslicarbazepinePhenytoin
Labeled forSeizures and epilepsySeizures and epilepsy
Boxed warningNoNo
Pharmacy cost (NADAC)$1.68 per tablet 200 mg tablet$0.145 per capsule 100 mg capsule
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?